18 January 2017
News and Views
Links and Services
The latest issue of Alimentary Pharmacology & Therapeutics examines the impact of dexlansoprazole on heartburn vs regurgitation in patients with gastro-esophageal reflux disease.
Gastro-esophageal reflux disease (GERD) is characterised by symptomatic heartburn and regurgitati
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors